IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities.
HIV-specific immunity during treatment interruption (ATI) and its relationship to viral rebound and immune responses during acute HIV infection. New methos for ATI monituring in cure trials.